T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$2.81B |
| 2 |
Boeing
BA
|
+$1.68B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.33B |
| 4 |
Amphenol
APH
|
+$1.11B |
| 5 |
CME Group
CME
|
+$902M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$3.65B |
| 2 |
Advanced Micro Devices
AMD
|
+$2.51B |
| 3 |
UnitedHealth
UNH
|
+$2.06B |
| 4 |
Uber
UBER
|
+$1.84B |
| 5 |
Adobe
ADBE
|
+$1.44B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.21% |
| 2 | Healthcare | 12.77% |
| 3 | Consumer Discretionary | 11.71% |
| 4 | Financials | 11.15% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Tractor Supply
TSCO
$19B
| $553M | 0.06% |
10,417,152
-3,020,468
| -22% | -$171M |
|
252
Micron Technology
MU
$1.03T
| $551M | 0.06% |
6,545,882
+4,352,225
| +198% | +$443M |
|
253
Humana
HUM
$46.7B
| $547M | 0.06% |
2,154,340
-90,098
| -4% | -$24.2M |
|
|
NVO
254
Novo Nordisk
NVO
$203B
| $546M | 0.06% |
6,345,118
-3,238,317
| -34% | -$350M |
|
|
ONC
255
BeOne Medicines Ltd
ONC
$40.6B
| $543M | 0.06% |
2,937,170
+237,082
| +9% | +$48.4M |
|
256
Western Digital
WDC
$157B
| $539M | 0.06% |
11,951,724
-3,847,456
| -24% | -$193M |
|
257
Yum China
YUMC
$16.4B
| $537M | 0.06% |
11,146,535
-35,384
| -0.3% | -$1.68M |
|
258
TransDigm Group
TDG
$68.3B
| $537M | 0.06% |
423,429
-37,498
| -8% | -$49.4M |
|
259
Sanofi
SNY
$105B
| $523M | 0.06% |
10,843,682
+5,091,304
| +89% | +$259M |
|
260
NXP Semiconductors
NXPI
$58.9B
| $520M | 0.06% |
2,503,562
+28,558
| +1% | +$6.5M |
|
261
MACOM Technology Solutions
MTSI
$23.7B
| $519M | 0.06% |
3,998,136
+1,120,510
| +39% | +$141M |
|
262
Baker Hughes
BKR
$63.8B
| $517M | 0.06% |
12,595,739
-1,832,844
| -13% | -$73.9M |
|
263
Floor & Decor
FND
$6.32B
| $514M | 0.06% |
5,151,580
-3,998,842
| -44% | -$430M |
|
264
Alibaba
BABA
$300B
| $510M | 0.06% |
6,010,789
-6,788,119
| -53% | -$641M |
|
265
Franco-Nevada
FNV
$45.5B
| $504M | 0.06% |
4,286,661
+400,384
| +10% | +$49.5M |
|
266
Verizon
VZ
$195B
| $503M | 0.06% |
12,586,254
-1,915,988
| -13% | -$80.8M |
|
267
Blackrock
BLK
$180B
| $502M | 0.06% |
490,000
-2,178
| -0.4% | -$2.21M |
|
268
Zebra Technologies
ZBRA
$17.9B
| $501M | 0.06% |
1,296,412
+86,766
| +7% | +$33.6M |
|
269
Pfizer
PFE
$150B
| $501M | 0.06% |
18,872,389
-2,084,603
| -10% | -$56.5M |
|
270
Western Alliance Bancorporation
WAL
$9.01B
| $499M | 0.06% |
5,968,526
+154,575
| +3% | +$13.6M |
|
|
BPMC
271
DELISTED
Blueprint Medicines
BPMC
| $495M | 0.06% |
5,679,089
+291,822
| +5% | +$26.7M |
|
272
Targa Resources
TRGP
$57.6B
| $492M | 0.06% |
2,756,419
+53,853
| +2% | +$9.66M |
|
273
IBM
IBM
$222B
| $491M | 0.06% |
2,234,539
-1,133,702
| -34% | -$252M |
|
274
GE HealthCare
GEHC
$32.6B
| $482M | 0.06% |
6,164,671
-408,038
| -6% | -$34.7M |
|
275
Idexx Laboratories
IDXX
$45B
| $481M | 0.06% |
1,162,947
-373,905
| -24% | -$164M |
|
Similar funds
T. Rowe Price Associates's Q4 2024 Portfolio in Review
As of Q4 2024, T. Rowe Price Associates held 3,110 positions worth $867B, down 0.13% from $869B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
T. Rowe Price Associates's Q4 2024 filing shows 92 new, 1,805 increased, 946 reduced and 96 closed positions. Its largest new stake was South Bow Corp: 12,337,055 shares worth $291M. The largest sale was Apple, an estimated $3.65B.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2024 buy was South Bow Corp: 12,337,055 shares worth $291M.
- T. Rowe Price Associates added most to Broadcom in Q4 2024, an estimated $2.81B increase.
- T. Rowe Price Associates's biggest Q4 2024 reduction was Apple, cutting an estimated $3.65B.
- T. Rowe Price Associates fully exited Tempus AI in Q4 2024, selling an estimated $292M.
- T. Rowe Price Associates's ten largest holdings make up 35% of its $867B portfolio in Q4 2024.
- T. Rowe Price Associates opened 92 new positions and closed 96 in Q4 2024.
- T. Rowe Price Associates's portfolio value fell 0.13% quarter-over-quarter to $867B.
Based on T. Rowe Price Associates's 13F filing for Q4 2024, filed 14 Feb 2025.